Cover Image

Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study

"Watch and wait" is becoming a common treatment option for patients with locally advanced rectal cancer (LARC) submitted to neoadjuvant treatment. However, currently, no clinical modality has an acceptable accuracy for predicting pathological complete response (pCR). The aim of this study...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marina Morais (Author), Telma Fonseca (Author), Diogo Melo-Pinto (Author), Isabel Prieto (Author), Ana Teresa Vilares (Author), Ana Luísa Duarte (Author), Patrícia Leitão (Author), Luís Cirnes (Author), José Carlos Machado (Author), Silvestre Carneiro (Author)
Format:	Book
Published:	MDPI AG, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
by: Parmida Sadat Pezeshki, et al.
Published: (2023)

Impact of Circulating Tumor DNA (ctDNA) in Patients with Gastrointestinal Malignancies
Published: (2020)

Prediction of the treatment response in ovarian cancer: a ctDNA approach
by: Mina Sharbatoghli, et al.
Published: (2020)

The Utility of Circulating Tumor DNA (ctDNA) Monitoring in Cancer Patients Who Are Pregnant or Planning to Become Pregnant
by: Stacey A. Cohen, et al.
Published: (2022)

How to Obtain a High Quality ctDNA in Lymphoma Patients: Preanalytical Tips and Tricks
by: Estelle Bourbon, et al.
Published: (2021)

Blood, Toil, and Taxoteres: Biological Determinants of Treatment-Induced ctDNA Dynamics for Interpreting Tumor Response
by: Christopher T. Boniface, et al.
Published: (2022)

Corrigendum: Blood, toil, and taxoteres: Biological determinants of treatment-induced ctDNA dynamics for interpreting tumor response
by: Christopher T. Boniface, et al.
Published: (2023)

Triazene salts: Design, synthesis, ctDNA interaction, lipophilicity determination, DFT calculation, and antiproliferative activity against human cancer cell lines
by: Joanna Cytarska, et al.
Published: (2019)

Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
by: Zhong W, et al.
Published: (2023)

Synthesis, Conformational Analysis and ctDNA Binding Studies of Flavonoid Analogues Possessing the 3,5-di-<i>tert</i>-butyl-4-hydroxyphenyl Moiety
by: Andromachi Tzani, et al.
Published: (2022)

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer
by: Julie M. Janssen, et al.
Published: (2022)

Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib
by: Chiara Dalle Fratte, et al.
Published: (2020)

Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis
by: Lucie Benesova, et al.
Published: (2022)

Sweet syndrome in a patient with rectal adenocarcinoma and HIV following neoadjuvant chemoradiation
by: Kamina Wilkerson, BS, et al.
Published: (2024)

Unraveling the role of gut microbiome in predicting adverse events in neoadjuvant therapy for rectal cancer
by: Jingxin Ma, et al.
Published: (2024)

Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
by: Aylin Alkan, et al.
Published: (2021)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
by: Ali Yaghobi Joybari, et al.
Published: (2021)

DNA Copy Number Aberrations and Expression of ABC Transporter Genes in Breast Tumour: Correlation with the Effect of Neoadjuvant Chemotherapy and Prognosis of the Disease
by: Matvey M. Tsyganov, et al.
Published: (2022)

Pediatric rectal foreign body: Value of 3-D CT reconstruction
by: Michael O'Laughlin, et al.
Published: (2020)

Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
by: Xu Y, et al.
Published: (2021)

Development of a method for digital assessment of tumor regression grade in patients with rectal cancer following neoadjuvant therapy
by: Dea Natalie Munch Jepsen, et al.
Published: (2022)

Lymph Nodes With Germinal Centers Are Not Associated With Tumor Response After Neoadjuvant Treatment in Locally Advanced Rectal Cancer
by: Ihsane El Otmani, et al.
Published: (2022)

Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients
by: Eun Young Kim, et al.
Published: (2024)

Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis
by: Shaoji Zhao, et al.
Published: (2024)

Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Shifen Zhang, et al.
Published: (2023)

Significance of Nutritional-Inflammatory Index as Predictors for Total Neoadjuvant Therapy-Induced Tumor Regression in Locally Advanced Rectal Cancer Patients
by: Zhao Z, et al.
Published: (2024)

LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
by: Zhang Y, et al.
Published: (2021)

Neoadjuvant chemotherapy is associated with worse prognosis in patients with advanced-stage epithelial ovarian cancer: Is it real?
by: Yiu-Tai Li, et al.
Published: (2024)

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
by: Elena De Mattia, et al.
Published: (2021)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
by: Weihao Li, et al.
Published: (2022)

Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
by: Liu Maoxi, et al.
Published: (2024)

Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology
by: Fangwei Li, et al.
Published: (2020)

The Addition of EGFR Inhibitors in Neoadjuvant Therapy for KRAS-Wild Type Locally Advanced Rectal Cancer Patients: A Systematic Review and Meta-Analysis
by: Xi Zhong, et al.
Published: (2020)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
by: Attila Paszt, et al.
Published: (2022)

Peculiarities of the distribution and expression dynamics of apoptosis marker Bax in patients with rectal cancer under the influence of neoadjuvant chemoradiotherapy with the usage of nitric oxide precursor
by: V. V. Golotyuk
Published: (2015)

Investigation into the effect of neoadjuvant therapy and tumor regression grade on the shrinkage of distal surgical margin in rectal cancer: A prospective case-control study
by: Ulaş Aday, et al.
Published: (2022)

Evaluation of the histopathologic status of rectal adenocarcinoma and its regional lymph nodes after neoadjuvant therapy, and its relation to the duration of disease-free survival
by: Farnaz Karimi, et al.
Published: (2022)

Comparison of prognosis between neoadjuvant imatinib and upfront surgery for GIST: A systematic review and meta-analysis
by: Zhen Liu, et al.
Published: (2022)

Prediction of Neoadjuvant Chemoradiotherapy Sensitivity in Patients With Esophageal Squamous Cell Carcinoma Using CT-Based Radiomics Combined With Clinical Features
by: Xindi Li, et al.
Published: (2024)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
by: Weisong Xue, et al.
Published: (2023)